Tải bản đầy đủ (.pdf) (3 trang)

Andersons pediatric cardiology 1666

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.39 KB, 3 trang )

33.HofmanN,TanHL,AldersM,etal.Yieldof
molecularandclinicaltestingforarrhythmia
syndromes:reportof15years’experience.
Circulation.2013;128(14):1513–1521.
34.ColanSD,LipshultzSE,LoweAM,etal.
Epidemiologyandcause-specificoutcomeof
hypertrophiccardiomyopathyinchildren:
findingsfromthepediatriccardiomyopathy
registry.Circulation.2007;115(6):773–781.
35.NugentAW,DaubeneyPE,ChondrosP,etal.
Clinicalfeaturesandoutcomesofchildhood
hypertrophiccardiomyopathy:resultsfroma
nationalpopulation-basedstudy.Circulation.
2005;112(9):1332–1338.
36.MaronBJ,RowinEJ,CaseySA,etal.
Hypertrophiccardiomyopathyinchildren,
Adolescents,andyoungadultsassociatedwith
lowcardiovascularmortalitywithcontemporary
managementstrategies.Circulation.
2016;133(1):62–73.
37.LipshultzSE,OravEJ,WilkinsonJD,etal.Risk
stratificationatdiagnosisforchildrenwith
hypertrophiccardiomyopathy:ananalysisof
datafromthepediatriccardiomyopathyregistry.
Lancet.2013;382(9908):1889–1897.
38.HarrisKM,SpiritoP,MaronMS,etal.
Prevalence,clinicalprofile,andsignificanceof


leftventricularremodelingintheend-stage
phaseofhypertrophiccardiomyopathy.


Circulation.2006;114(3):216–225.
39.MaronBJ,TajikAJ,RuttenbergHD,etal.
Hypertrophiccardiomyopathyininfants:clinical
featuresandnaturalhistory.Circulation.
1982;65(1):7–17.
40.Ostman-SmithI,WettrellG,KeetonB,etal.
Echocardiographicandelectrocardiographic
identificationofthosechildrenwith
hypertrophiccardiomyopathywhoshouldbe
consideredathigh-riskofdyingsuddenly.
CardiolYoung.2005;15(6):632–642.
41.OlivottoI,CecchiF,CaseySA,etal.Impactof
atrialfibrillationontheclinicalcourseof
hypertrophiccardiomyopathy.Circulation.
2001;104(21):2517–2524.
42.SiontisKC,GeskeJB,OngK,etal.Atrial
fibrillationinhypertrophiccardiomyopathy:
prevalence,clinicalcorrelations,andmortalityin
alargehigh-riskpopulation.JAmHeartAssoc.
2014;3(3):e001002.
43.MaronBJ,OlivottoI,BelloneP,etal.Clinical
profileofstrokein900patientswith
hypertrophiccardiomyopathy.JAmColl
Cardiol.2002;39(2):301–307.
44.CecchiF,OlivottoI,GistriR,etal.Coronary


microvasculardysfunctionandprognosisin
hypertrophiccardiomyopathy.NEnglJMed.
2003;349(11):1027–1035.

45.OlivottoI,CecchiF,GistriR,etal.Relevanceof
coronarymicrovascularflowimpairmentto
long-termremodelingandsystolicdysfunction
inhypertrophiccardiomyopathy.JAmColl
Cardiol.2006;47(5):1043–1048.
46.OlivottoI,GirolamiF,SciagraR,etal.
Microvascularfunctionisselectivelyimpairedin
patientswithhypertrophiccardiomyopathyand
sarcomeremyofilamentgenemutations.JAm
CollCardiol.2011;58(8):839–848.
47.FrankS,BraunwaldE.Idiopathichypertrophic
subaorticstenosis.Clinicalanalysisof126
patientswithemphasisonthenaturalhistory.
Circulation.1968;37(5):759–788.
48.HardarsonT,DelaCalzadaCS,CurielR,
GoodwinJF.Prognosisandmortalityof
hypertrophicobstructivecardiomyopathy.
Lancet.1973;2(7844):1462–1467.
49.McKennaW,DeanfieldJ,FaruquiA,etal.
Prognosisinhypertrophiccardiomyopathy:role
ofageandclinical,electrocardiographicand
hemodynamicfeatures.AmJCardiol.
1981;47(3):532–538.
50.SpiritoP,ChiarellaF,CarratinoL,etal.Clinical



×